ClinicalTrialsFinder

Relapsed or Refractory AML and Other Hematologic Malignancies Clinical Trials in Musashino, Tokyo

1 recruitingMusashino, Tokyo, Japan

Showing 1–1 of 1 trials

Recruiting
Phase 1

Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Other Hematologic Malignancies.

Relapsed or Refractory AML and Other Hematologic Malignancies
Kyowa Kirin Co., Ltd.156 enrolled17 locationsNCT06812104